"Holbæk Sygehus er et af fire sygehuse i Region Sjælland, som har en akutafdeling, der er specialiseret i hurtig behandling af akut opstående sygdomme"

During the past decade, Holbæk Sygehus conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 1 clinical trials were completed. i.e. 5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holbæk Sygehus" #1 sponsor was "Bayer" with 7 trials, followed by "Holbaek Sygehus" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "University of Southern Denmark" with 3 trials sponsored and "Herlev Hospital" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holbæk Sygehus" #1 collaborator was "Holbaek Sygehus" with 9 trials as a collaborator, "Rigshospitalet, Denmark" with 8 trials as a collaborator, "Odense University Hospital" with 5 trials as a collaborator, "Zealand University Hospital" with 5 trials as a collaborator and "Hillerod Hospital, Denmark" with 4 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Holbæk Sygehus" are "Heart Failure" (4 trials), "Atrial Fibrillation" (3 trials), "Chronic Kidney Disease" (3 trials), "Crohn Disease" (3 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Holbæk Sygehus" in a lesser frequency.

Most popular intervention types in "Holbæk Sygehus" are "Drug" (22 trials), "Other" (11 trials), "Behavioral" (6 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Finerenone (BAY94-8862)" (3 trials), "Ozanimod" (3 trials), "Progesterone" (2 trials) and "6% Hydroxyethyl starch 130/0.4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holbæk Sygehus" are 39 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Holbæk Sygehus". undefined are not yet recruiting, 18 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Holbæk Sygehus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Holbæk Sygehus, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".